Enhancing Organizational Capacity and Provider Readiness to Treat OUD With Buprenorphine/Naloxone: System Level Strategies

Open this course Estimated time to complete activity: 1 hour Audience: Providers
Credits Available: AMAAAPAANCCASWBACPECPH UAN #JA4008162-9999-20-2406-H01-P
Activity Release Date: October 22, 2020 Expiration Date: October 21, 2021

This module will review the barriers to, and models for medications for OUD implementation, screening, brief intervention, and referral to treatment models of care, and collaborative care as a way of expanding medications for OUD. 

Learning Objectives

  • List at least four overlapping characteristics of successful MOUD models of care
  • Describe the necessary organizational and clinical changes needed to address drug
    use in primary care settings
  • Apply the roadmap (plan, do, study, act) to implement quality improvement processes
    for each of the five key clinical changes necessary in addressing substance use
    disorders
  • Differentiate between language and phrasing that focused on the person from disease-
    based language
  • Address workflow considerations in the identification and management of OUDs
  • Discuss the role of motivational interviewing in addressing the treatment of OUDs
    with patients
  • Define the collaborative care model

Note:

Jointly provided by Postgraduate Institute for Medicine and HealthHIV